- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02953574
Daily Sleep Enhancement for Hospitalized People With Dementia Following a Nursing Protocol
Daily Sleep Enhancement for Hospitalized People With Dementia Following a 7 Step Nursing Protocol: a Quasi-experimental Pilot Study
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- diagnosis of dementia of any severity and type
- Allocation to geriatric rehabilitation treatment
Exclusion Criteria:
- sleep related respiratory or moving related disorders or Parasomnia
- delirium
- end of life care
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: daily sleep enhancement nursing protocol
A 7 step nursing protocol. Each step is daily provided to the demented patient through a nurse by bedtime. Step 1: serve a late snack Step 2: evening care (brush teeth, get pyjama on, go to toilette) Step 3: note and treat physical circumstances that restrain sleep (pain, obstipation,...) Step 4: ensure comfortable position abed Step 5: assist to eliminate stressful situation (calm, reorientating conversation) Step 6: turn off the light Step 7: care for a silent environment (turn off Television, radio and "do not disturb"-sign at the door) |
|
|
Aucune intervention: usual nursing care
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Bedtime in minutes
Délai: Daily for up to 14 days from date of giving informed consent to hospital discharge
|
Protocol of daily bedtime
|
Daily for up to 14 days from date of giving informed consent to hospital discharge
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Sleeps through the night consistently, 5 point ordinal scale from "severe compromised" to "not compromised"
Délai: Every second day for up to 14 days from date of giving informed consent to hospital discharge
|
Subitem of the Outcome 'Sleep' from the Nursing Outcome Classification (NOC) Scale:
|
Every second day for up to 14 days from date of giving informed consent to hospital discharge
|
|
Inappropriate napping, 5 point ordinal scale ranging from "sever" to "none"
Délai: Every second day for up to 14 days from date of giving informed consent to hospital discharge
|
Subitem of the Outcome 'Sleep' from the Nursing Outcome Classification (NOC) Scale:
|
Every second day for up to 14 days from date of giving informed consent to hospital discharge
|
|
Cognitive performance (Mini-mental-status-test score)
Délai: Once in first three days after giving informed consent and another time 7 or 14 days later
|
Mini-mental-status-test score (range 0-30). Any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment |
Once in first three days after giving informed consent and another time 7 or 14 days later
|
|
Physical performance measured with the Handgrip strength test
Délai: Once in first three days after giving informed consent and another time 7 or 14 days later
|
Handgrip strength in Pascal
|
Once in first three days after giving informed consent and another time 7 or 14 days later
|
|
Use of drugs promoting sleep (sedative neuroleptics, hypnotics, sedative antidepressant in the time between 18:00-24:00) (nominal variable: yes or no)
Délai: day 1,2 and day 6,7 or 13,14
|
Medical charts review for sedative neuroleptics (e.g.
Quetiapine, Haloperidol), sedative antidepressives (e.g.
Trazodon), hypnotics present (Benzodiazepines, benzodiazepine-like drugs) in the time between 18:00-24:00 (nominal variable: yes or no )
|
day 1,2 and day 6,7 or 13,14
|
|
Medical chart review for discharge domicile after hospitalisation (nursing home, home, other institution, other)
Délai: day 7 or 14
|
Domicile after hospital discharge
|
day 7 or 14
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Application frequency of the nursing (ritual) protocol
Délai: Every day for up to 14 days from date of giving informed consent to hospital discharge
|
Daily protocol of the received and of the refused interventions of the nursing ritual (frequency)
|
Every day for up to 14 days from date of giving informed consent to hospital discharge
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Hanna Burkhalter, Dr. sc. med., Center of Sleep Medicine
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2016-00780
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .